These models must be able to correctly describe the relevant physiology and need to be identified on each single individual: the ability of a model to provide reliable predictions of the glucose and insulin time courses allows the development of robust control algorithms for automatic glucose control in the management of T1DM patients. The gene discussed is INS; the disease is type 1 diabetes mellitus.